ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

63
Analysis
Health CareAustralia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
02 Dec 2017 07:18

Aussie Healthcare Daily: 1 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare & biotech companies as well as developments...

Logo
255 Views
Share
07 Jul 2017 07:24

Time to Look at the Laggards in Aussie Healthcare

Australian Growth stocks have under-performed in the past four years, but they generally perform well in a rising global interest rate...

Logo
453 Views
Share
bearishBlackmores Ltd
24 Mar 2017 15:18

Financial Forensics - The Short-Seller's Indispensable Tool-Kit

Financial forensics remains an indispensable part of the short-seller's tool-kit. In this report, Evidente updates and expands its analysis of...

Logo
414 Views
Share
21 Feb 2017 08:05

Australian Growth Stocks: The Big Short (Still)

Four months ago, Evidente published a post suggesting that Australian growth stocks were over-priced The Big Short: Australian Growth Stocks and...

Logo
477 Views
Share
bearishMylan NV
14 Nov 2016 03:55

Generic Drug Antitrust Inquiry: A Primer

Recent news stories reporting looming criminal antitrust charges against certain generic drug companies (and possibly executives) are wighing on...

Share
x